Search
Patexia Research
Case number 1:20-cv-00430

Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. > Summary

Court Case Number 1:20-cv-00430

Filing Date Mar 26, 2020

Termination Date Aug 10, 2022

Court Delaware District Court

Status Judgment - Judgment on Consent

Appeal2022-2153

JudgesRichard G. Andrews

Plaintiff Attorneys

29

Salix Pharmaceuticals
Attorney Name: Cameron P. Clark
Morris Nichols Arsht & Tunnell

Salix Pharmaceuticals
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

Valeant Pharmaceuticals Ireland Limited
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

Valeant Pharmaceuticals Ireland Limited
Attorney Name: Cameron P. Clark
Morris Nichols Arsht & Tunnell

Valeant Pharmaceuticals Ireland Limited
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

Alfasigma S.p.A.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

Alfasigma S.p.A.
Attorney Name: Cameron P. Clark
Morris Nichols Arsht & Tunnell

Alfasigma S.p.A.
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

Salix Pharmaceuticals
Attorney Name: Scott K. Reed
Venable

Salix Pharmaceuticals
Attorney Name: Steven C. Kline
Venable

Salix Pharmaceuticals
Attorney Name: Shannon K. Clark
Venable

Bausch Health Companies
Attorney Name: Scott K. Reed
Venable

Alfasigma S.p.A.
Attorney Name: Scott K. Reed
Venable

Bausch Health Companies
Attorney Name: Steven C. Kline
Venable

Alfasigma S.p.A.
Attorney Name: Steven C. Kline
Venable

Bausch Health Companies
Attorney Name: Shannon K. Clark
Venable

Alfasigma S.p.A.
Attorney Name: Shannon K. Clark
Venable

Salix Pharmaceuticals
Attorney Name: Allan S. Myerson
Massachusetts Institute of Technology

Salix Pharmaceuticals
Attorney Name: Daniel A. Apgar
Venable

Salix Pharmaceuticals
Attorney Name: Alexis M. McJoynt
Venable

Salix Pharmaceuticals
Attorney Name: Damien N. Dombrowski
Venable

Salix Pharmaceuticals
Attorney Name: Becky E. Steephenson
Venable

Bausch Health Companies
Attorney Name: Robert J. Brown
Troutman Pepper Hamilton Sanders LLP

Salix Pharmaceuticals
Attorney Name: David R. Taft
Long Island University

Salix Pharmaceuticals
Attorney Name: Dario Braga
Salix Pharmaceuticals

Salix Pharmaceuticals
Attorney Name: Lorin Johnson
Salix Pharmaceuticals

Salix Pharmaceuticals
Attorney Name: Robert Spurr
Salix Pharmaceuticals

Bausch Health Companies
Attorney Name: James Baker
Mayer Brown

Defendant Attorneys

26

Alvogen Pb Research & Development LLC
Attorney Name: Karen E. Keller
Shaw Keller LLP

Norwich Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP

Norwich Pharmaceuticals
Attorney Name: David M. Fry
Shaw Keller LLP

Norwich Pharmaceuticals
Attorney Name: Matthew J. Becker
Axinn Veltrop & Harkrider

Norwich Pharmaceuticals
Attorney Name: Stacie L. Ropka
Axinn Veltrop & Harkrider

Norwich Pharmaceuticals
Attorney Name: Matthew S. Murphy
Axinn Veltrop & Harkrider

Norwich Pharmaceuticals
Attorney Name: Chad A. Landmon
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Matthew J. Becker
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Rebecca L. Clegg
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: David M. Fry
Shaw Keller LLP

Norwich University
Attorney Name: Chad A. Landmon
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Matthew S. Murphy
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Stacie L. Ropka
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Aziz Burgy
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Ricardo Camposanto
Axinn Veltrop & Harkrider

Norwich University
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP

Norwich University
Attorney Name: Thomas C. Mahl
University at Buffalo

Norwich University
Attorney Name: Carl L. Berg
Duke University

Norwich University
Attorney Name: Gary K. Schoolnik
Visby Medical, Inc.

Norwich University
Attorney Name: Richard Bergstrom
Indiana University

Alvogen
Attorney Name: Paul Fackler
Alvogen

Alvogen
Attorney Name: Zhen Mei
Alvogen

Alvogen
Attorney Name: Jyoti Sachdeva
Alvogen

Norwich University
Attorney Name: Michael J. Zaworotko
UNIVERSITY OF LIMERICK

Norwich University
Attorney Name: Herbert L Dupont
Baylor College of Medicine

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
10765667 Methods for treating irritable bowel syndrome (IBS) Sep 8, 2020
10709694 Methods of treating hepatic encephalopathy Jul 14, 2020
10703763 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Jul 7, 2020
10456384 Methods for treating irritable bowel syndrome (IBS) Oct 29, 2019
10335397 Methods of treating hepatic encephalopathy Jul 2, 2019
10314828 Methods of treating hepatic encephalopathy Jun 11, 2019
09629828 Methods of treating traveler's diarrhea and hepatic encephalopathy Apr 25, 2017
09421195 Methods of treating hepatic encephalopathy Aug 23, 2016
09271968 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Mar 1, 2016
08969398 Methods of treating hepatic encephalopathy Mar 3, 2015
08946252 Methods of treating traveler's diarrhea and hepatic encephalopathy Feb 3, 2015
08853231 Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin Oct 7, 2014
08835452 Polymorphic forms α, β and γ of rifaximin Sep 16, 2014
08829017 Methods of treating traveler's diarrhea and hepatic encephalopathy Sep 9, 2014
08741904 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Jun 3, 2014
08642573 Methods of treating hepatic encephalopathy Feb 4, 2014
08518949 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Aug 27, 2013
08309569 Methods for treating diarrhea-associated irritable bowel syndrome Nov 13, 2012
08193196 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Jun 5, 2012
08158644 Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin Apr 17, 2012
08158781 Polymorphic forms α, β and γ of rifaximin Apr 17, 2012
07915275 Use of polymorphic forms of rifaximin for medical preparations Mar 29, 2011
07906542 Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin Mar 15, 2011
07902206 Polymorphic forms α, β and γ of rifaximin Mar 8, 2011
07612199 Polymorphic forms α, β, and γ of rifaximin Nov 3, 2009
07045620 Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations May 16, 2006
Menu